Literature DB >> 21458969

[Idiopathic nephrotic syndrome in children: Incidence, clinical presentation, and outcome in the county of Gironde, France].

S Ernould1, A Godron2, J-R Nelson3, C Rigothier4, B Llanas2, J Harambat2.   

Abstract

AIMS: To estimate the incidence and describe the clinical presentation and outcome (steroid responsiveness, clinical course, complications) of idiopathic nephrotic syndrome in children in a population-based retrospective study.
METHODS: Using local registries and the hospital discharge diagnosis system from two centers, all new cases of idiopathic nephrotic syndrome were identified in Gironde (France) between January 1992 and May 2008. To estimate incidence, population-based denominators were obtained from the National Institute for Statistics and Economic Studies (INSEE). Clinical data were collected from medical charts.
RESULTS: Ninety-nine cases of idiopathic nephrotic syndrome were reported (66 boys, 18 non-Caucasians) with an incidence of 2.3/100,000 (CI, 1.8-3.0) children less than 15 years. Ninety patients (91%) had steroid-sensitive nephrotic syndrome (SSNS) and nine (9%) were steroid-resistant (SRNS). The median time to remission in SSNS was 11 days. Relapses occurred in 75 (83%) children with SSNS with a median of four relapses (range, 1-32). The cumulative relapse-free incidence was 60% at 10 years after diagnosis in SSNS and 13% of patients aged 18 years old or over still had active disease. In SSNS, the only significant factor associated with steroid dependency or use of non steroid drugs was the time to initial response to steroids greater than 14 days. Nineteen children (19%) experienced severe complications of nephrotic syndrome including 11 bacterial infections and two thromboembolic complications. Two children with SRNS, of whom one was initially steroid-responsive, developed end-stage renal failure.
CONCLUSION: The incidence and outcome of idiopathic nephrotic syndrome in Gironde are comparable to the rates found in other studies. The disease may have a long course and the time for response to steroids at disease onset is the main predictor of steroid dependency and of use of non steroid agents.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21458969     DOI: 10.1016/j.arcped.2011.02.012

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  6 in total

1.  TNFα pathway blockade ameliorates toxic effects of FSGS plasma on podocyte cytoskeleton and β3 integrin activation.

Authors:  Martin Bitzan; Sima Babayeva; Anil Vasudevan; Paul Goodyer; Elena Torban
Journal:  Pediatr Nephrol       Date:  2012-04-27       Impact factor: 3.714

2.  High incidence of idiopathic nephrotic syndrome in East Asian children: a nationwide survey in Japan (JP-SHINE study).

Authors:  Kaori Kikunaga; Kenji Ishikura; Chikako Terano; Mai Sato; Fumiyo Komaki; Yuko Hamasaki; Satoshi Sasaki; Kazumoto Iijima; Norishige Yoshikawa; Koichi Nakanishi; Hitoshi Nakazato; Takeshi Matsuyama; Takashi Ando; Shuichi Ito; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2016-09-02       Impact factor: 2.801

3.  Recurrent focal segmental glomerulosclerosis: a discrete clinical entity.

Authors:  Elena Torban; Martin Bitzan; Paul Goodyer
Journal:  Int J Nephrol       Date:  2012-01-11

4.  [Idiopathic nephrotic syndrome (INS) in children in Dakar: about 40 cases].

Authors:  Younoussa Keita; Ahmed Tall Lemrabott; Assane Sylla; Babacar Niang; El Hadji Fary Ka; Chérif Mohamed Dial; Aliou Abdoulaye Ndongo; Amadou Sow; Claude Moreira; Abdou Niang; Ousmane Ndiaye; Boucar Diouf; Mouhamadou Guélaye Sall
Journal:  Pan Afr Med J       Date:  2017-03-21

5.  Time to Relapse and Its Predictors among Children with Nephrotic Syndrome in Comprehensive Specialized Hospitals, Tigray, Ethiopia, 2019.

Authors:  Miliete Gebrehiwot; Mekuria Kassa; Haftom Gebrehiwot; Migbar Sibhat
Journal:  Int J Pediatr       Date:  2020-11-22

6.  Children with nephrotic syndrome have greater bone area but similar volumetric bone mineral density to healthy controls.

Authors:  R J Moon; R D Gilbert; A Page; L Murphy; P Taylor; C Cooper; E M Dennison; J H Davies
Journal:  Bone       Date:  2013-10-18       Impact factor: 4.398

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.